ctrl K

Price Alert

Hepion Pharmaceuticals In... (HEPA)

NASDAQ: HEPA · Real-Time Price · USD

0.07

0.01 (22.59%)

At close: Jun 09, 2025, 3:45 PM

Hepion Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	406.41K	14.79M	51.19M	91.35M
Short-Term Investments	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	-564.84K	-619.38K
Other Long-Term Assets	n/a	364.19K	426.17K	583.33K
Receivables	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	n/a	n/a	n/a	n/a
Total Current Assets	1.61M	17.49M	56.5M	97.45M
Property-Plant & Equipment	n/a	242.37K	132.21K	456.46K
Goodwill & Intangibles	n/a	n/a	3.19M	5.06M
Total Long-Term Assets	n/a	606.56K	3.75M	6.1M
Total Assets	1.61M	18.09M	60.24M	103.55M
Account Payables	220.2K	2.35M	2.67M	2.45M
Deferred Revenue	n/a	n/a	4.8M	2.51M
Short-Term Debt	2.9M	n/a	53.61K	266.65K
Other Current Liabilities	23.68K	386K	2.22M	4.36M
Total Current Liabilities	3.14M	5.29M	7.89M	8.21M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	333.19K	5.43M	2.09M	1.89M
Total Long-Term Liabilities	333.19K	5.52M	2.5M	2.35M
Total Liabilities	3.48M	10.81M	10.39M	10.56M
Total Debt	2.9M	209.02K	53.61K	316.99K
Common Stock	14.00	482.00	7.62K	7.62K
Retained Earnings	-237.82M	-224.63M	-175.7M	-133.5M
Comprehensive Income	8.35K	-78.78K	-90.17K	0.00
Shareholders Equity	-1.86M	7.28M	49.86M	93M
Total Investments	n/a	n/a	-564.84K	-619.38K